Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 1/20 | 0.55 |
| ▸ | BACE1 | P56817 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.45 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.44 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.44 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19677511 | 1.00 | AR (0.55) | ARBACE1MAPK1MAPTHTT | |
| SCHEMBL19677510 | 1.00 | AR (0.55) | ARBACE1MAPK1MAPTHTT | |
| SCHEMBL19001619 | 0.92 | AR (0.52) | ARBACE1MAPK1MAPTHTT | |
| SCHEMBL12267199 | 0.90 | AR (0.51) | ARBACE1MAPTLMNAPOLB | |
| SCHEMBL7090393 | 0.90 | AR (0.64) | ARMAPK1MAPTHTTSMN1; SMN2 | |
| SCHEMBL12314967 | 0.87 | AR (0.49) | ARBACE1MAPK1MAPTHTT | |
| SCHEMBL24948597 | 0.85 | AR (0.56) | ARMAPK1MAPTHTTSMN1; SMN2 | |
| SCHEMBL12517404 | 0.84 | AR (0.58) | ARMAPK1MAPTHTTSMN1; SMN2 | |
| SCHEMBL7088414 | 0.84 | AR (0.58) | ARMAPTHTTSMN1; SMN2LMNA | |
| SCHEMBL13190962 | 0.84 | BACE1 (0.43) | ARBACE1MAPK1MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119688860-A | Method for simultaneously detecting bisphenol diglycidyl ether and p-phenylenediamine antioxidants | 中山大学 | 2025-03-25 | — | — | CN | claimed |
| CN-119438427-A | Method for simultaneously detecting 27 bisphenol compounds in dairy products | 重庆市计量质量检测研究院 | 2025-02-14 | — | — | CN | claimed |
| CN-114755316-B | Method for screening dangerous substances in food contact material and application | 广州质量监督检测研究院 | 2024-02-27 | — | — | CN | claimed |
| CN-114755316-A | Method for screening dangerous substances in food contact material and application | 广州质量监督检测研究院 | 2022-07-15 | — | — | CN | claimed |
| US-20030149219-A1 | Process for manufacturing a hydroxyester derivative intermediate and epoxy resins prepared therefrom | BORIACK CLINTON J (US) | 2003-08-07 | — | — | US | claimed |
| US-6534621-B2 | Epoxidizing an alpha-halohydrin intermediate produced from an in situ halide substitution-deesterification of an alpha-hydroxy ester derivative | DOW GLOBAL TECHNOLOGIES INC. | 2003-03-18 | — | — | US | claimed |
| US-20020045707-A1 | Process for manufacturing a hydroxyester derivative intermediate and epoxy resins prepared therefrom | DOW GLOBAL TECHNOLOGIES INC. | 2002-04-18 | — | — | US | claimed |
| CN-119688860-A | Method for simultaneously detecting bisphenol diglycidyl ether and p-phenylenediamine antioxidants | 中山大学 | 2025-03-25 | — | — | CN | disclosed |
| CN-119438427-A | Method for simultaneously detecting 27 bisphenol compounds in dairy products | 重庆市计量质量检测研究院 | 2025-02-14 | — | — | CN | disclosed |
| CN-114755316-B | Method for screening dangerous substances in food contact material and application | 广州质量监督检测研究院 | 2024-02-27 | — | — | CN | disclosed |
| US-11760892-B2 | Aqueous pigment dispersions | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2023-09-19 | — | — | US | disclosed |
| US-11760892-B2 | Aqueous pigment dispersions | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2023-09-19 | — | — | US | disclosed |
| CN-114755316-A | Method for screening dangerous substances in food contact material and application | 广州质量监督检测研究院 | 2022-07-15 | — | — | CN | disclosed |
| US-20130245129-A1 | DIGLYCIDIC ETHER DERIVATIVE THERAPEUTICS AND METHODS FOR THEIR USE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2013-09-19 | — | — | US | disclosed |
| US-20110230556-A1 | Diglycidic Ether Derivative Therapeutics and Methods for Their Use | THE UNITED STATES GOVERNMENT | 2011-09-22 | — | — | US | disclosed |
| US-20110230556-A1 | Diglycidic Ether Derivative Therapeutics and Methods for Their Use | THE UNITED STATES GOVERNMENT | 2011-09-22 | — | — | US | disclosed |
| WO-2010000066-A1 | DIGLYCIDIC ETHER DERIVATIVE THERAPEUTICS AND METHODS FOR THEIR USE | BRITISH COLUMBIA CANCER AGENCY BRANCH (CA) | 2010-01-07 | — | — | WO | disclosed |
| US-20030149219-A1 | Process for manufacturing a hydroxyester derivative intermediate and epoxy resins prepared therefrom | BORIACK CLINTON J (US) | 2003-08-07 | — | — | US | disclosed |
| US-6534621-B2 | Epoxidizing an alpha-halohydrin intermediate produced from an in situ halide substitution-deesterification of an alpha-hydroxy ester derivative | DOW GLOBAL TECHNOLOGIES INC. | 2003-03-18 | — | — | US | disclosed |
| US-20020045707-A1 | Process for manufacturing a hydroxyester derivative intermediate and epoxy resins prepared therefrom | DOW GLOBAL TECHNOLOGIES INC. | 2002-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130245129-A1 | DIGLYCIDIC ETHER DERIVATIVE THERAPEUTICS AND METHODS FOR THEIR USE | MAN2B2, UGCG, KLK3 | AR 179/4885BACE1 3576/4885MAPK1 2686/4885 |
| US-20110230556-A1 | Diglycidic Ether Derivative Therapeutics and Methods for Their Use | MAN2B2, KLK3, UGCG | AR 125/4885BACE1 3674/4885MAPK1 2347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.